Table 2.
VAS, ASES, Constant scores for both groups
| Score | Group A | Group B | p-value |
|---|---|---|---|
| VAS | |||
| Preoperative | 6.1±1.3 | 6.0±1.2 | 0.571 |
| 4- or 6-Week follow-up | 5.9±1.1 | 4.4±1.5 | <0.001* |
| 3-Month follow-up | 2.1±1.2 | 3.1±1.1 | <0.001* |
| 6-Month follow-up | 1.2±1.0 | 1.4±1.1 | 0.445 |
| 2-Year follow-up | 0.8±1.0 | 0.7±0.8 | 0.481 |
| ASES | |||
| Preoperative | 49.4±13.0 | 51.0±13.4 | 0.539 |
| 2-Year follow-up | 87.2±9.6 | 88.2±8.5 | 0.595 |
| Constant | |||
| Preoperative | 56.5±10.4 | 57.3±9.7 | 0.651 |
| 2-Year follow-up | 86.4±7.8 | 84.9±8.1 | 0.315 |
Values are presented as mean±standard deviation. Group A: sono-guided subacromial corticosteroid injection, Group B: control.
VAS: visual analog scale, ASES: American Shoulder and Elbow Surgeons.
*
Significant improvement of VAS, ASES, and Constant score within groups was found between preoperative and 2-year postoperative in both groups (p<0.001). Statistically significant association with 4- or 6-week and 3-month follow-up pain (p<0.001).